$12.33 7.1%
SAVA Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Cassava Sciences

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.


Cassava Sciences
Price $12.33
Target Price Sign up
Volume 1,850,000
Market Cap $552M
Year Range $9.84 - $30.11
Dividend Yield 0%
Revenue per Employee $90,308
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2403.8M-3.8M25M-20M0.580
Q4 '232.3M4.1M-4.1M-21M-23M-0.500
Q3 '2304.4M-4.4M-26M-28M-0.610
Q2 '2303.9M-3.9M-26M-29M-0.630
Q1 '2304.5M-4.5M-24M-26M-0.580

Insider Transactions View All

ROBERTSON SANFORD filed to buy 886,851 shares at $17.5.
August 24 '23
Barry Richard filed to buy 293,477 shares at $16.7.
August 23 '23
Barry Richard filed to buy 276,906 shares at $16.8.
August 23 '23
Barry Richard filed to buy 275,000 shares at $25.8.
March 8 '23
Barry Richard filed to buy 197,724 shares at $26.1.
March 8 '23

Congress Trading View All

Politician Filing Date Type Size
Christopher Jacobs
Republican
Jan 20, 23 Buy $1K - $15K
Christopher Jacobs
Republican
Dec 12, 22 Sell $1K - $15K
Christopher Jacobs
Republican
Nov 16, 22 Buy $1K - $15K

What is the Market Cap of Cassava Sciences?

The Market Cap of Cassava Sciences is $552M.

How Many People Work at Cassava Sciences?

As of our latest update, Cassava Sciences employed approximately 26 people worldwide. However, it's important to note that Cassava Sciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Cassava Sciences' revenue per employee?

$90,308. To calculate Cassava Sciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Cassava Sciences?

Currently, the price of one share of Cassava Sciences stock is $12.33.

How can I analyze the SAVA stock price chart for investment decisions?

The SAVA stock price chart above provides a comprehensive visual representation of Cassava Sciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cassava Sciences shares. Our platform offers an up-to-date SAVA stock price chart, along with technical data analysis and alternative data insights.

Does SAVA offer dividends to its shareholders?

As of our latest update, Cassava Sciences (SAVA) does not offer dividends to its shareholders. Investors interested in Cassava Sciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cassava Sciences?

Some of the similar stocks of Cassava Sciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.